Applied Therapeutics Inc (NASDAQ:APLT) price on Thursday, December 26, rose 4.11% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $0.89.
A look at the stock’s price movement, the close in the last trading session was $0.85, moving within a range at $0.7726 and $0.9. The beta value (5-Year monthly) was 2.018. Turning to its 52-week performance, $10.62 and $0.78 were the 52-week high and 52-week low respectively. Overall, APLT moved -90.75% over the past month.
Applied Therapeutics Inc’s market cap currently stands at around $103.16 million, with investors looking forward to this quarter’s earnings report slated for in January.
The average forecast suggests down to a -99.00% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 533.6k, representing a -94.66% decline on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that APLT is a 100% Sell. On the other hand, the stock is on average a Hold as suggested by medium term indicators while long term indicators are putting the stock in 50% Sell category.
3 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 3 recommend APLT as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
APLT’s current price about -44.25% and -85.58% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 17.49, while 7-day volatility ratio is 13.37% and 14.93% in the 30-day chart. Further, Applied Therapeutics Inc (APLT) has a beta value of 1.76, and an average true range (ATR) of 0.41. Analysts have given the company’s stock an average 52-week price target of $4.5, forecast between a low of $4 and high of $5. Looking at the price targets, the low is -349.44% off current price level while to achieve the yearly target high, price needs to move -461.8%. Nonetheless, investors will most likely welcome a -405.62% jump to $4.5 which is the analysts’ median price.
If we refocus on Applied Therapeutics Inc (NASDAQ:APLT), historical trading data shows that trading volumes averaged 8.29 over the past 10 days and 5.13 million over the past 3 months. The company’s latest data on shares outstanding shows there are 116.36 million shares.
The 25.56% of Applied Therapeutics Inc’s shares are in the hands of company insiders while institutional holders own 88.02% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 14.18 million on 2024-11-29, giving us a short ratio of 3.25. The data shows that as of 2024-11-29 short interest in Applied Therapeutics Inc (APLT) stood at 1360.0000000000002 of shares outstanding, with shares short rising to 12.14 million registered in 2024-10-31. Current price change has pushed the stock -73.53% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the APLT stock continues to rise going into the next quarter.
